Sanofi-aventis

Sanofi-aventis is the major multinational pharmaceutical firm in South Africa and one of the world's leading pharmaceutical corporations, with about 11 000 scientists and 100 000 people working to enhance health and welfare. In Paris, France, we have our global headquarters. Sanofi is a worldwide healthcare company with a strong focus on patients' needs.

Sanofi has key competencies in the field of healthcare with its growth platforms in consumer healthcare, diabetes, new products, and animal health, as well as a broad and balanced presence in both conventional and emerging markets. Sanofi has strengthened its position in biotechnology and rare illnesses with the acquisition of Genzyme. Sanofi's Animal Health Division, Merial, is a world-leading, innovation-driven animal health firm that offers a wide variety of medicines to improve animal health, well-being, and performance. Sanofi-aventis concentrates its efforts on seven primary therapeutic areas: cardiovascular, thrombosis, oncology, CNS, metabolic disorders, internal medicine, and vaccines. Sanofi-aventis offers excellent healthcare to millions of people.

In the fields of thrombosis, cardiovascular illness, sleep disorders, bone disease, epilepsy, diabetes, and cancer, the sanofi-aventis portfolio of marketed medications includes numerous medicines that are world leaders in their respective classifications. Sanofi-aventis sells a wide range of products in South Africa to fulfill the country's healthcare needs.

Founded: 2004
Address: 2 Bond St, Grand Central, Midrand, 1685, South Africa
Type: Public Company

Industries: Pharmaceuticals

Website: http://www.sanofi.com